Emily Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Emily Yu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Dylan Glaser
Department of Biomedical Sciences, School of Medicine, University of Missouri—Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA
1 shared publication - Eric S. Chai
School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64108, USA
1 shared publication - Xiang-Ping Chu
Department of Biomedical Sciences, University of Missouri–Kansas City School of Medicine, United States
1 shared publication - Yuyang Chu
Department of Orthopedic Surgery, Detroit Medical Center, School of Medicine, Wayne State University, Detroit, MI 48201, USA
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Addiction & Prevention
- Vol. 1 (2) , 12
Proton-Sensing Signaling in Substance Use Disorders: GPR4 and ASICs as an Emerging Frontier in Addiction Neurobiology
Substance use disorders (SUDs) involve drug-evoked adaptations in reward, stress, and relapse circuits. We propose that extracellular pH fluctuations may provide an additional, context-dependent regulatory signal. Neural activity, vesicle release, respiration, metabolism, lactate/proton transport, and vascular responses can produce local acidifying or alkalinizing changes whose direction and magnitude depend on compartment and buffering. Acid-sensing ion channels (ASICs) can respond rapidly to appropriate acidic excursions, whereas proton-sensing G protein-coupled receptors (GPCRs), including GPR4 and GPR68, may encode changes in ambient proton-dependent signaling over longer timescales. ASIC studies demonstrate effects on cocaine-related plasticity and behavior; global GPR4 deletion alters cocaine-induced locomotor responses and sensitization but does not identify the responsible cell population or establish a role in reinforcement or relapse. We critically examine the uncertain sign of synaptic pH transients, GPR65 and GPR132, astrocyte–neuron metabolic coupling, and potential human measurement strategies. We propose direct pH recording combined with circuit-resolved causal perturbations to test this two-arm model without presuming that drug exposure produces uniform acidosis.
- 3 November 2026
- Published by MDPI AG in Addiction & Prevention
- Vol. 1 (2) , 12
Open AccessProton-Sensing Signaling in Substance Use Disorders: GPR4 and ASICs as an Emerging Frontier in Addiction Neurobiology
Substance use disorders (SUDs) involve drug-evoked adaptations in reward, stress, and relapse circuits. We propose that extracellular pH fluctuations may provide an additional, context-dependent regulatory signal. Neural activity, vesicle release, respiration, metabolism, lactate/proton transport, and vascular responses can produce local acidifying or alkalinizing changes whose direction and magnitude depend on compartment and buffering. Acid-sensing ion channels (ASICs) can respond rapidly to appropriate acidic excursions, whereas proton-sensing G protein-coupled receptors (GPCRs), including GPR4 and GPR68, may encode changes in ambient proton-dependent signaling over longer timescales. ASIC studies demonstrate effects on cocaine-related plasticity and behavior; global GPR4 deletion alters cocaine-induced locomotor responses and sensitization but does not identify the responsible cell population or establish a role in reinforcement or relapse. We critically examine the uncertain sign of synaptic pH transients, GPR65 and GPR132, astrocyte–neuron metabolic coupling, and potential human measurement strategies. We propose direct pH recording combined with circuit-resolved causal perturbations to test this two-arm model without presuming that drug exposure produces uniform acidosis.